Lease roundup: Steve Ross’ 15 CityPlace snags Fox Rothschild, Inmobiliaria Brom hits Aventura leasing spree

Steve Ross’ 15 CityPlace snagged law firm Fox Rothschild, and Inmobiliaria Brom signed a slew of tenants in Aventura.

Aria Launches Allegro as a Standalone Product to Address the Surge in Usage Monetization in the AI Era

Aria Systems unbundles Aria Allegro as consumption-based monetization becomes the enterprise default. SAN FRANCISCO, May 19, ...
TMCnet

Realbotix Provides Update on Nasdaq Listing

Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix" or the "Parent Company"), a leading AI humanoid robot manufacturer for social tasks, is pleased to provide an update on its ...

Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS…

Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies ...

How Jenny Morris sparked fury to change the Australian music industry forever

Jenny Morris was at the peak of her pop powers in the late 1980s when she launched a one-woman campaign that provoked howls ...

Let’s Get Social Returns to ICSC Las Vegas 2026 with Expanded Sponsor Roster

Let's Get Social, the annual commercial real estate networking gathering held alongside ICSC Las Vegas, returns Monday, ...

Here Comes The Drop: How TMRW Music Dominated 60% of ARIA’s Dance Chart In a Single Week

Billboard caught up with the top brass at TMRW Music and etcetc for a closer look at Australia’s vibrant dance space and how the Sydney label group is lifting the tempo.

Acumen expects ALTITUDE-AD top-line results in late 2026 while targeting a mid-2027 IND for 2 EBD candidates

Q1 2026. Management View "In the first quarter, we continued to advance sabirnetug through our Phase II ALTITUDE-AD trial, bu ...
TMCnet

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril ...
Business Insider

Let's Get Social Returns to ICSC Las Vegas 2026 as Premier CRE Networking Event

The 12th annual kickoff cocktail party brings together commercial real estate's top social media influencers, brokers, and industry leaders on May 18, 2026, at the Aria Resort. Las Vegas, NV, Nevada, ...